Clayton, VICTORIA4 Active Studies

Ankylosing Spondylitis Clinical Trials in Clayton, VICTORIA

Find 4 actively recruiting ankylosing spondylitis clinical trials in Clayton, VICTORIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
945
Enrolling

Recruiting Ankylosing Spondylitis Studies in Clayton

RecruitingClayton, VICTORIANCT04665206

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

This is an open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, and biological activity of VT3989 administered, alone or in combination, once daily in patients wit...

336 participants
Vivace Therapeutics, Inc
View Study Details
RecruitingClayton, VICTORIANCT04521231

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

The Phase I part of the study aims to evaluate the safety, efficacy, and tolerability of subcutaneous (SC) blinatumomab for treatment of Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leu...

281 participants
Amgen
View Study Details
RecruitingClayton, VICTORIANCT06726148

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Phase I: Characterize safety and tolerability of ECI830 as a single agent and in combination with ribociclib and fulvestrant. Identify dose range for optimization/recommended dose for future studies. ...

280 participants
Novartis Pharmaceuticals
View Study Details
RecruitingClayton, VICTORIANCT06465953

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

This study will enroll participants with myelodysplastic syndromes (MDS) with an Isocitrate dehydrogenase protein, 1 (IDH1) mutation, who have not received treatment with a hypomethylating agent previ...

48 participants
Institut de Recherches Internationales Servier
View Study Details

About Ankylosing Spondylitis Clinical Trials in Clayton

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Clayton, VICTORIA. These studies are seeking a combined 945 participants. Research is being sponsored by Vivace Therapeutics, Inc, Amgen, Novartis Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Clayton — FAQ

Are there ankylosing spondylitis clinical trials in Clayton?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Clayton, VICTORIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Clayton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Clayton research site will contact you about next steps.

Are clinical trials in Clayton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Clayton studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Clayton are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov